Job/Unit: O21413
/KAP1
Date: 16-01-13 11:59:07
Pages: 11
O. R. Martin, J. Mlynarski et al.
FULL PAPER
H) ppm. 13C NMR (100 MHz, CDCl3/TMS): δ = 200.2, 152.4,
136.2, 128.7, 128.6, 128.3, 128.2, 128.1, 95.6, 78.3, 67.1, 66.8, 46.7,
solution of osmium tertoxide in tert-butyl alcohol (0.034 mL,
0.0034 mmol, 1 mol-%) and the solution was stirred vigorously at
25 °C. After 24 h, the reaction was quenched by the addition of
40% aq. NaHSO4 (10 mL) and the mixture was extracted with
EtOAc (3ϫ 25 mL). The combined organic phases were dried
45.6, 26.1, 25.0, 24.5 ppm. IR (film): ν = 3401, 2981, 2938, 2897,
˜
1701, 1407, 1379, 1254, 1213, 1060, 868, 748, 697 cm–1. HRMS
(ESI): m/z calcd. for C14H17NNaO4 [M + Na]+ 286.104979; found
286.105020; calcd. for C14H19NNaO5 [M
304.115543; found 304.115604. C14H19NO5 (281.31): calcd. C orated under reduced pressure. The residue was purified by column
+ H2O +
Na]+ (Na2SO4), filtered through a cotton plug, and the solvent was evap-
59.78, H 6.81, N 4.98; found C 59.66, H 6.81, N 4.69.
chromatography (SiO2; PE/EtOAc, 1:1) to afford 8 (0.097 g, 85%)
as a 1:1 mixture of diastereoisomers 8c and 8d.
The enantiomeric purity (Ͼ99%) was determined by HPLC analy-
sis of the alcohols (S)-7 and (R)-7, obtained by reduction of the
aldehydes (S)-1 and (R)-1. CSP-HPLC {chiralpak AD-H,
DAICEL; hexane/2-propanol, 90:10; 1 mLmin–1; 21 °C, λ = 208
nm; Rt = 10.5 [(S)-7], 11.8 min [(R)-7]}. To an ice-cold solution of
aldehyde 1 (0.031 g, 0.117 mmol, 1 equiv.) in a 1:1 mixture of THF/
iPrOH (1 mL), was added solid NaBH4 (13.3 mg, 0.351 mmol,
3 equiv.). The mixture was stirred for 30 min at this temperature,
then acetone (0.02 mL) was added and the reaction mixture was
concentrated to dryness under reduced pressure. The residue was
partitioned between H2O (10 mL) and EtOAc (10 mL) and the
phases were separated. The aqueous phase was extracted with
EtOAc (3ϫ 10 mL) and the combined organic phases were dried
with anhydrous Na2SO4 and concentrated by rotary evaporation.
The residue was purified by flash chromatography over silica gel
(PE/EtOAc, 3:2) to give pure alcohol 7 (27.5 mg, 88%) as a color-
less oil. The same procedure was performed with ent-1.
Benzyl (5S)-5-[(1S,2R)-1,2-Dihydroxy-3-oxobutyl]-2,2-dimethyl-1,3-
oxazolidine-3-carboxylate (8c): [α]2D0 –53.1 (c = 1.11, CHCl3). 1H
NMR (600 MHz, CDCl3/TMS): δ = 7.38–7.29 (m, 5 H), 5.12 (s, 2
H), 4.38 (ddd, J = 10.5, 6.4, 3.8 Hz, 1 H), 4.13 (dd, J = 7.6, 6.2 Hz,
1 H), 3.75 (s, 1 H), 3.58 (d, J = 5.6 Hz, 1 H), 3.50 (m, 2 H), 2.83
(s, 1 H), 2.38 (s, 3 H), 1.64 (s, 3 H), 1.55 (s, 3 H) ppm. 13C NMR
(150 MHz, CDCl3/TMS): δ (mixture of rotamers) = 209.7, 152.6,
152.2, 136.4, 128.5, 128.0, 127.8, 94.4, 93.9, 77.4, 73.9, 73.7, 71.7,
67.3, 66.6, 47.5, 46.8, 27.9, 25.9, 24.4 ppm. MS (ESI): m/z = 360.0
[M + Na]+.
Benzyl (5S)-5-[(1R,2S)-1,2-Dihydroxy-3-oxobutyl]-2,2-dimethyl-1,3-
oxazolidine-3-carboxylate (8d): [α]2D0 +13.5 (c = 1.09, CHCl3). 1H
NMR (600 MHz, CDCl3/TMS): δ = 7.38–7.29 (m, 5 H), 5.11 (s, 2
H), 4.22 (s, 1 H), 4.18 (dt, J = 8.9, 6.6 Hz, 1 H), 3.93 (t, J = 5.6 Hz,
1 H), 3.88–3.78 (br. m, 2 H), 3.52 (t, J = 9.0 Hz, 1 H), 2.91 (s, 1
H), 2.30 (s, 3 H), 1.57 (s, 3 H), 1.46 (s, 3 H) ppm. 13C NMR
(150 MHz, CDCl3/TMS): δ (mixture of rotamers) = 206.8, 152.8,
152.3, 136.4, 128.5, 128.0, 127.9, 94.6, 78.0, 72.9, 72.8, 72.5, 67.2,
66.68, 48.3, 47.4, 27.0, 26.7, 25.9, 25.2, 24.1 ppm. MS (ESI): m/z =
360.0 [M + Na]+.
Dihydroxylation of (E)-9: To
a solution of (E)-9 (0.152 g,
0.50 mmol, 1 equiv.) in a mixture of tBuOH/H2O (1:1, 5 mL) was
added methylsulfonamide (0.048 g, 0.50 mmol, 1 equiv.) and AD-
mix-β (0.750 g, 1.50 g/mmol, 1 equiv.) and the solution was stirred
vigorously at room temp. (ca. 25 °C). After 24 h, the reaction was
quenched by the addition of 40% aq. NaHSO4 (10 mL) and the
mixture was extracted with EtOAc (3ϫ 25 mL). The combined or-
ganic phases were dried (Na2SO4), filtered through a cotton plug,
and the solvent was evaporated under reduced pressure. The resi-
due was purified by column chromatography (SiO2, PE/EtOAc, 1:1)
to afford 8 (0.151 g, 90%) as a 1:1 mixture of diastereoisomers 8a
and 8b.
Benzyl (5R)-2,2-Dimethyl-5-[(1E)-3-oxobut-1-en-1-yl]-1,3-oxazolid-
ine-3-carboxylate [(E)-9] and Benzyl (5R)-2,2-Dimethyl-5-[(1Z)-3-
oxobut-1-en-1-yl]-1,3-oxazolidine-3-carboxylate [(Z)-9]: To a solu-
tion of 1 (0.790 g, 3.0 mmol, 1 equiv.) in anhydrous dichlorometh-
ane (20 mL) was added slowly a solution of 1-(triphenylphosphor-
anylidene)-2-propanone (1.150 g, 3.60 mmol, 1.2 equiv.) in anhy-
drous dichloromethane (8 mL) and the reaction mixture was stirred
at 25 °C for 3 h. The solvent was then evaporated and the residue
was purified by column chromatography over silica gel (PE/Et2O,
3:1) to afford (E)-9 (0.527 g, 58%) and (Z)-9 (0.110 g, 12%).
Benzyl (5S)-5-[(1R,2R)-1,2-Dihydroxy-3-oxobutyl]-2,2-dimethyl-1,3-
oxazolidine-3-carboxylate (8a): [α]2D0 –24.9 (c = 1.07, CHCl3). 1H
NMR (400 MHz, CDCl3/TMS): δ = 7.44–7.28 (m, 5 H), 5.13 (s, 2
H), 4.39 (d, J = 2.8 Hz, 1 H), 4.20 (td, J = 7.8, 6.3 Hz, 1 H), 4.00
(t, J = 8.3 Hz, 1 H), 3.90–3.80 (br. m, 1 H), 3.72 (d, J = 3.9 Hz, 1
H), 3.56 (dd, J = 10.5, 8.1 Hz, 1 H), 2.31 (s, 3 H), 2.20 (d, J =
9.6 Hz, 1 H), 1.64 (s, 3 H), 1.54 (s, 3 H) ppm. 13C NMR (75 MHz,
CDCl3/TMS): δ = 207.7, 152.4, 136.4, 128.5, 128.0, 127.9, 94.3,
76.6, 74.1, 72.5, 66.6, 48.0, 26.4, 25.2, 24.4 ppm. HRMS (ESI): m/z
Compound (E)-9: [α]2D0 –17 (c = 1.21, CHCl3); Rf = 0.27 (SiO2; PE/
1
Et2O, 1:1). H NMR (400 MHz, CDCl3/TMS): δ = 7.43–7.27 (m,
5 H), 6.71 (dd, J = 16.0, 5.4 Hz, 1 H), 6.34 (d, J = 16.0 Hz, 1 H),
5.12 (s, 2 H), 4.75–4.60 (m, 1 H), 4.00–3.80 (m, 1 H), 3.37–3.21 (m,
1 H), 2.27 (s, 3 H), 1.65 (s, 3 H), 1.58 (s, 3 H) ppm. 13C NMR
(100 MHz, CDCl3/TMS): δ (mixture of rotamers) = 197.6, 152.5,
151.8, 141.5, 136.3, 135.9, 131.4, 128.4, 127.9, 127.7, 94.5, 93.9,
72.9, 72.7, 67.2, 66.5, 50.6, 49.8, 27.3, 27.0, 25.9, 25.4, 24.3 ppm.
calcd. for C17H23NNaO6 [M
360.141812.
+
Na]+ 360.141758; found
IR (film): ν = 2984, 2939, 2882, 1700, 1680, 1636, 1407, 1352, 1253,
˜
Benzyl (5S)-5-[(1S,2S)-1,2-Dihydroxy-3-oxobutyl]-2,2-dimethyl-1,3-
oxazolidine-3-carboxylate (8b): [α]2D0 +11.2 (c = 1.04, CHCl3). 1H
NMR (600 MHz, CDCl3/TMS): δ = 7.39–7.21 (m, 5 H), 5.19–5.07
(br. m, 2 H), 4.30 (dt, J = 9.0, 6.2 Hz, 1 H), 4.11–4.08 (br. m, 1 H),
4.05–3.98 (br. m, 1 H), 3.88–3.74 (br. m, 1 H), 3.74–3.67 (s, 1 H),
3.47–3.35 (br. m, 1 H), 2.69 (s, 1 H), 2.29 (s, 3 H), 1.65 (s, 3 H),
1.45 (s, 3 H) ppm. 13C NMR (150 MHz, CDCl3): δ (mixture of
rotamers) = 207.1, 152.7, 152.1, 136.4, 136.1, 128.5, 128.1, 127.9,
94.8, 94.2, 77.4, 75.0, 74.6, 72.4, 67.4, 66.7, 47.7, 46.9, 27.2, 26.1,
25.7, 25.4, 24.3 ppm. HRMS (ESI): m/z calcd. for C17H23NNaO6
[M + Na]+ 360.141759; found 360.141694.
1214, 1084, 1048, 977, 907, 877, 735, 698 cm–1. HRMS (ESI): m/z
calcd. for C17H22NNaO4 [M + Na]+ 326.13628; found 326.13682.
Compound (Z)-9: [α]2D0 –180 (c = 1.29, CHCl3); Rf = 0.46 (SiO2; PE/
1
Et2O, 1:1). H NMR (400 MHz, CDCl3/TMS): δ = 7.41–7.26 (m,
5 H), 6.27 (d, J = 11.5 Hz, 1 H), 6.15 (dd, J = 11.5, 6.4 Hz, 1 H),
5.42–5.32 (m, 1 H), 5.11 (s, 2 H), 4.16–4.07 (m, 1 H), 3.19–3.05 (m,
1 H), 2.23 (s, 3 H), 1.64 (s, 3 H), 1.54 (s, 3 H) ppm. 13C NMR
(100 MHz, CDCl3/TMS): δ (mixture of rotamers) = 198.1, 152.1,
144.5, 144.1, 136.5, 128.4, 128.2, 127.9, 127.8, 94.1, 93.7, 71.9, 71.5,
67.0, 66.4, 50.2, 49.2, 31.0, 27.2, 26.1, 25.3, 24.2 ppm. IR (film): ν
˜
Dihydroxylation of (Z)-9: To
0.34 mmol, 1 equiv.) in a mixture of tBuOH/THF/H2O (9:3:2,
5 mL) was added NMO (0.047 g, 0.40 mmol, 1.18 equiv.) and a
a solution of (Z)-9 (0.103 g, = 2961, 2899, 1698, 1623, 1407, 1353, 1257, 1214, 1182, 1087, 1046,
1015, 875, 789, 698 cm–1. HRMS (ESI): m/z calcd. for
C17H22NNaO4 [M + Na]+ 326.13628; found 326.13625.
8
www.eurjoc.org
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 0000, 0–0